DYADIC INTERNATIONAL
1.9100
25-November-24 16:45:01
15 minutes delayed
Stocks
-0.0200
-1.04%
Today's range
1.7900 - 2.0000
ISIN
N/A
Source
NASDAQ
-
Dyadic Advancing Towards Human Clinical Trial of its SARS-CoV-2-S-RBD vaccine candidate, DYAI-100
18 Mar 2021 08:30:00 By Nasdaq GlobeNewswire
-
Dyadic Announces Scientific Achievements Reported During ZAPI Stakeholders Virtual Web Meeting
09 Mar 2021 08:30:00 By Nasdaq GlobeNewswire